These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 11874856)
21. Consecutive outbreaks of Vibrio cholerae O139 and V. cholerae O1 cholera in a fishing village near Karachi, Pakistan. Siddiqui FJ; Bhutto NS; von Seidlein L; Khurram I; Rasool S; Ali M; Zafar A; Deen JL; Clemens JD; Nizami Q; Bhutta ZA Trans R Soc Trop Med Hyg; 2006 May; 100(5):476-82. PubMed ID: 16443247 [TBL] [Abstract][Full Text] [Related]
22. Changing profile of Vibrio cholerae O1, O139 in Delhi & its periphery (2003-2005). Sharma NC; Mandal PK; Dhillon R; Jain M Indian J Med Res; 2007 May; 125(5):633-40. PubMed ID: 17642498 [TBL] [Abstract][Full Text] [Related]
23. Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal. Cholera Working Group, International Centre for Diarrhoeal Diseases Research, Bangladesh. Lancet; 1993 Aug; 342(8868):387-90. PubMed ID: 8101899 [TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics of non-O1/non-O139 Vibrio cholerae isolates and polymerase chain reaction analysis of their virulence factors. Lee YL; Hung PP; Tsai CA; Lin YH; Liu CE; Shi ZY J Microbiol Immunol Infect; 2007 Dec; 40(6):474-80. PubMed ID: 18087626 [TBL] [Abstract][Full Text] [Related]
25. Electrophoretic mobility and immune response of outer membrane proteins of Vibrio cholerae O139. Pal S; Sasmal D; Guhathakurta B; Nair GB; Bhattacharya SK; Mallick R; Datta A FEMS Immunol Med Microbiol; 1996 Sep; 15(2-3):143-8. PubMed ID: 8880140 [TBL] [Abstract][Full Text] [Related]
26. Antimicrobial peptides in the duodenum at the acute and convalescent stages in patients with diarrhea due to Vibrio cholerae O1 or enterotoxigenic Escherichia coli infection. Shirin T; Rahman A; Danielsson Å; Uddin T; Bhuyian TR; Sheikh A; Qadri SS; Qadri F; Hammarström ML Microbes Infect; 2011 Nov; 13(12-13):1111-20. PubMed ID: 21782033 [TBL] [Abstract][Full Text] [Related]
27. [Epidemic condition and biological characteristics of non-O1/non-O139 Vibrio cholerae in Haizhu District of Guangzhou]. Xu SH; Li YX; Li ST; Wu Q; Sun FQ; Huang F; Zeng AF Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Dec; 44(12):1087-90. PubMed ID: 21215109 [TBL] [Abstract][Full Text] [Related]
28. Phage types of Vibrio cholerae O1 and O139 in the past decade in India. Sarkar BL; Bhowmick TS; Das M; Rajendran K; Nair GB Jpn J Infect Dis; 2011; 64(4):312-5. PubMed ID: 21788707 [TBL] [Abstract][Full Text] [Related]
29. Protein profiles in mucosal and systemic compartments in response to Vibrio cholerae in a mouse pulmonary infection model. Kang SS; Baik JE; Yang JS; Cho K; Yun CH; Han SH Microb Pathog; 2015 Sep; 86():10-7. PubMed ID: 26150210 [TBL] [Abstract][Full Text] [Related]
30. Nitric oxide and inflammatory bowel disease: evidence for local intestinal production in children with active colonic disease. Levine JJ; Pettei MJ; Valderrama E; Gold DM; Kessler BH; Trachtman H J Pediatr Gastroenterol Nutr; 1998 Jan; 26(1):34-8. PubMed ID: 9443117 [TBL] [Abstract][Full Text] [Related]
31. [Comparison of colonization ability of O1 and O139 Wang JZ; Yan MY; Lu X; Kan B Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Dec; 51(12):1102-1107. PubMed ID: 29262492 [No Abstract] [Full Text] [Related]
32. Development of a 5-minute rapid test for detecting Vibrio cholerae O139. Thattiyaphong A; Okada K; Khangrang S; Nispa W; Sawanpanyalert P; Honda T Southeast Asian J Trop Med Public Health; 2013 May; 44(3):448-55. PubMed ID: 24050076 [TBL] [Abstract][Full Text] [Related]
33. Nitric oxide production during Vibrio cholerae infection. Janoff EN; Hayakawa H; Taylor DN; Fasching CE; Kenner JR; Jaimes E; Raij L Am J Physiol; 1997 Nov; 273(5):G1160-7. PubMed ID: 9374715 [TBL] [Abstract][Full Text] [Related]
34. Characterization of environmental Vibrio cholerae serogroups O1 and O139 in the Pearl River Estuary, China. Li X; Wang D; Li B; Zhou H; Liang S; Ke C; Deng X; Kan B; Morris JG; Cao W Can J Microbiol; 2016 Feb; 62(2):139-47. PubMed ID: 26674584 [TBL] [Abstract][Full Text] [Related]
36. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age. Saha A; Chowdhury MI; Khanam F; Bhuiyan MS; Chowdhury F; Khan AI; Khan IA; Clemens J; Ali M; Cravioto A; Qadri F Vaccine; 2011 Oct; 29(46):8285-92. PubMed ID: 21907255 [TBL] [Abstract][Full Text] [Related]
37. Vibrio cholerae non-O1 as a causal pathogen in cholera patients in Yangon, Myanmar. Oo KN; Than WM; Win T; Thida M; Aung KS J Diarrhoeal Dis Res; 1995 Sep; 13(3):176-9. PubMed ID: 8568194 [TBL] [Abstract][Full Text] [Related]
38. Evolutionary genetic analysis of the emergence of epidemic Vibrio cholerae isolates on the basis of comparative nucleotide sequence analysis and multilocus virulence gene profiles. O'Shea YA; Reen FJ; Quirke AM; Boyd EF J Clin Microbiol; 2004 Oct; 42(10):4657-71. PubMed ID: 15472325 [TBL] [Abstract][Full Text] [Related]
39. Individuals with Le(a+b-) blood group have increased susceptibility to symptomatic vibrio cholerae O1 infection. Arifuzzaman M; Ahmed T; Rahman MA; Chowdhury F; Rashu R; Khan AI; LaRocque RC; Harris JB; Bhuiyan TR; Ryan ET; Calderwood SB; Qadri F PLoS Negl Trop Dis; 2011 Dec; 5(12):e1413. PubMed ID: 22216364 [TBL] [Abstract][Full Text] [Related]
40. Virulence-associated genes and molecular characteristics of non-O1/non-O139 Vibrio cholerae isolated from hepatitis B cirrhosis patients in China. Jiang F; Bi R; Deng L; Kang H; Gu B; Ma P Int J Infect Dis; 2018 Sep; 74():117-122. PubMed ID: 29969728 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]